[Latest] Global Employer of Record EOR Market Size/Share Worth USD 15.89 Billion by 2035 at a 9.24% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

[Latest] Global Employer of Record EOR Market Size/Share Worth USD 15.89 Billion by 2035 at a 9.24% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Employer of […]

Plaintiffs’ Evidence Will Be Heard in Cases Alleging J&J’s Talc Products Caused Women’s Ovarian Cancer, Announced Levin Papantonio Attorney Chris Tisi

PENSACOLA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) — A U.S. District Court Special Master in the talc multidistrict litigation (MDL) against Johnson & Johnson (J&J) entered an Opinion, reaffirming that plaintiffs may present expert testimony supporting general causation to the jury. Specifically, Special Master, Hon. L. Wolfson, former Chief Judge for the District of New

Care@Home for Life Appoints Aurelian Anghelusiu as Chief Relationship Officer to Lead Human-Centered Growth Strategy

Miami, FL, Jan. 21, 2026 (GLOBE NEWSWIRE) — Care@Home for Life, a company dedicated to redefining how Americans age at home, today announced the appointment of Aurelian Anghelusiu as Chief Relationship Officer. In this role, Anghelusiu will lead the company's relationship strategy across clients, families, advisors, and strategic partners as the organization continues its mission

Plaintiffs’ Evidence Will Be Heard in Cases Alleging J&J’s Talc Products Caused Women’s Ovarian Cancer, Announced Levin Papantonio Attorney Chris Tisi

Plaintiffs' Evidence Will Be Heard in Cases Alleging J&J's Talc Products Caused Women's Ovarian Cancer, Announced Levin Papantonio Attorney Chris Tisi GlobeNewswire January 22, 2026 PENSACOLA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) — A U.S. District Court Special Master in the talc multidistrict litigation (MDL) against Johnson & Johnson (J&J) entered an Opinion, reaffirming that

Care@Home for Life Appoints Aurelian Anghelusiu as Chief Relationship Officer to Lead Human-Centered Growth Strategy

Care@Home for Life Appoints Aurelian Anghelusiu as Chief Relationship Officer to Lead Human-Centered Growth Strategy GlobeNewswire January 22, 2026 Miami, FL, Jan. 21, 2026 (GLOBE NEWSWIRE) — Care@Home for Life, a company dedicated to redefining how Americans age at home, today announced the appointment of Aurelian Anghelusiu as Chief Relationship Officer. In this role, Anghelusiu

Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock

(NASDAQ:AXGN), ALACHUA, Fla. and TAMPA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) — Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced the pricing of an upsized underwritten public offering of 4,000,000 shares of its common stock at a price to the

Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock

Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock GlobeNewswire January 22, 2026 ALACHUA, Fla. and TAMPA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) — Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced the pricing of an upsized

Inaugural Cures Conference to be held on Thursday, February 5, 2026 in NYC

Panelists include leaders in the fields of science, medicine and technology: Jack Hidary, Dr. Edward Neilan, Dr. Shoshana Shendelman, Dr. John Greely, Louis Reese and Nadia Harhen. Introducing the inaugural Cures Conference to be held in NYC on Thursday, February 5, 2026. The Cures Conference convenes scientists, physicians, pharmaceutical executives, tech leaders, and government officials

New nanoparticle technology offers hope for hard-to-treat diseases

New nanoparticle technology offers hope for hard-to-treat diseases GlobeNewswire January 22, 2026 Sydney, Australia, Jan. 21, 2026 (GLOBE NEWSWIRE) — A newly published paper in Nature Nanotechnology details groundbreaking nanoparticle technology, with research led by University of Technology Chair Professor in Nanomedicine Bingyang Shi. A newly published perspective article in Nature Nanotechnology details groundbreaking nanoparticle

New nanoparticle technology offers hope for hard-to-treat diseases

Sydney, Australia, Jan. 21, 2026 (GLOBE NEWSWIRE) — A newly published paper in Nature Nanotechnology details groundbreaking nanoparticle technology, with research led by University of Technology Chair Professor in Nanomedicine Bingyang Shi. A newly published perspective article in Nature Nanotechnology details groundbreaking nanoparticle technology to eliminate harmful, disease-causing proteins in the body. The technology marks

Scroll to Top